AMY POTTER: Open Payments
NPI 1144658469 · YORK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,072 in 55 payments from 19 companies in 2025. Trend: 2023 $1,118 · 2024 $962 · 2025 $1,072
Food & beverage: $1,072
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $214 |
| Lilly USA, LLC | 11 | $187 |
| Novo Nordisk Inc | 6 | $122 |
| Janssen Pharmaceuticals, Inc | 2 | $77 |
| GlaxoSmithKline, LLC. | 3 | $73 |
| PFIZER INC. | 4 | $72 |
| Seqirus USA Inc | 2 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $43 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
Products named: VRAYLAR, MOUNJARO, JARDIANCE, SPRAVATO, Ozempic, UBRELVY, Wegovy, TRELEGY ELLIPTA.
Industry payments across PA — which companies pay providers there.
